The m-PIMA™ HIV-1/2 VL test is now commercially available in select countries, and has received CE-IVD marking and WHO prequalification. This product is not available in the United States.


Fully automated nucleic acid testing platform combines the accuracy of molecular testing with a short turnaround time, allowing same day treatment decisions and consultations with patients. The portable m-PIMA™ Analyser brings HIV early infant diagnosis and HIV viral load testing to a wide range of decentralized settings, bypassing delays and inefficiencies associated with centralized testing.


There are no reviews yet.

Be the first to review “m-PIMA™ ANALYSER”

Your email address will not be published. Required fields are marked *